ArticleJournal of the American Heart Association2026
Association Between Stress Hyperglycemia Ratio and Cardiovascular Outcomes in Patients Who Underwent Complex Percutaneous Coronary Intervention According to Different Glycemic Status.
Article in Journal of the American Heart Association, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundComplex percutaneous coronary intervention is associated with higher risk of long-term worse cardiovascular outcomes than noncomplex procedures. Stress hyperglycemia ratio (SHR), a biomarker to reflect relative hyperglycemia, has been shown to predict risk of cardiovascular events in patients with coronary artery disease. However, whether SHR-related cardiovascular risk could be seen in patients who underwent complex percutaneous coronary intervention who are at high risk of cardiovascular events remained undetermined.
methodsThis prospective cohort study consecutively recruited 12 220 patients who underwent complex percutaneous coronary intervention from January 2017 to December 2018 at Fuwai Hospital. Patients were categorized according to baseline SHR tertiles (tertile 1: ≤ 0.765; T2: 0.765-0.879 and T3: > 0.879). The primary end point was cardiovascular events including cardiovascular death, nonfatal myocardial infarction, and nonfatal stroke.
resultsDuring a median 3-year follow-up, 389 cardiovascular events (3.6% of the 10 772 patients who completed follow-up) were recorded. Overall, per 1-unit increase in SHR values was associated with 1.62-fold (95% CI, 1.10-2.38) risk of cardiovascular events after adjusting for confounding factors. Upon stratification by glycemic status, in the fully adjust model, elevated SHR was associated with increased risk of cardiovascular events in diabetic patients (T3 vs. T1; hazard ratio [HR], 1.67 [95% CI, 1.20-2.32]).
conclusionsWe found that elevated SHR levels were associated with increased risk of cardiovascular events at long-term follow-up in patients who underwent complex percutaneous coronary intervention, especially in those with diabetes, suggesting that it could help in risk stratification and prognosis in this population.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.